From July 2 to 3, representatives from more than 2,000 Chinese and Israeli companies attended the 4th China-Israel Investment Summit in Zhuhai, South China's Guangdong province.
In addition to road shows, there were forums on topics such as intelligent manufacturing, the digital economy, biomedicine, smart cities and intellectual property rights.
Israel is one of China's major trading partners in the Middle East, while China is Israel's largest trading partner in Asia and its third largest trading partner in the world. Last year, trade volume between the two countries reached $13.12 billion, a 15.6-percent year-on-year increase.
China and Israel's cooperation in technological innovation is highly complementary, said Zhao Dongliang, director of the Changzhou Israel Innovation Park, the first experimental zone for innovation cooperation established by the two governments.
"The basic research of industries in Israel is better, and the country emphasizes core technology research and development, while China is adept in business model innovation, so the combination of the two has promising prospects," Zhao said.
CollPlant is an Israeli regenerative medicine company that focuses on 3D bio-printing and developing tissue repair products. The product it promoted at the summit was a bio-ink made of artificial collagen from tobacco leaves for soft tissue repair. In Changzhou Israel Innovation Park, Collplant and Flon Holding Group, a Chinese company specializing in medical instruments and bio-materials, have established a joint venture to develop collagen made from plants.
At the summit, more than 140 Israeli technology companies and about 800 Chinese companies sought opportunities to cooperate through Business-to-Business (B2B) matchmaking seminars.
扫一扫在手机打开当前页  |
